Editorial - Natural Products and Gut Microbiome Metabolism in Hepatobiliary Gastrointestinal Diseases

Le résumé fourni par la source

The gut microbiome, recognized as a pivotal metabolic organ, engages in intricate crosstalk with the intestine and liver, profoundly influencing the pathogenesis and progression of various diseases, particularly hepatobiliary and gastrointestinal disorders. Natural products are extensively metabolized by the gut microbiota, generating bioactive metabolites with potential therapeutic benefits or adverse effects. This Special Collection highlights the latest advances in unraveling these complex host–microbiome interactions, offering novel insights into therapeutic strategies for the prevention and management of diverse diseases, with a special focus on hepatobiliary and gastrointestinal conditions.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.